Nonnucleoside Reverse Transcriptase Inhibitor-Containing Regimens Are Associated with Increased Satisfaction with Sexual Life [1]

Journal of Acquired Immune Deficiency Syndromes

Volumn 34, Issue 5, 2003, Pages 532-534

  Murri, Rita ^a   Fantoni, Massimo ^a   Del Borgo, Cosmo ^a   Longo, Benedetta ^a   Deiana, Gilda ^a   Visonà, Raffaella ^b   Zambelli, Agostino ^c   Barchi, Enrico ^d   Orchi, Nicoletta ^e   Bosco, Oliviero ^f   Wu, Albert W ^g  

^a CATHOLIC UNIVERSITY   (Italy)

^b SANT ANNA HOSPITAL   (Italy)

^c UNIVERSITY OF MILAN   (Italy)

^d S MARIA NUOVA HOSPITAL   (Italy)

^e NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^f HIV Screening Clinic   (Italy)

^g JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR; VIRUS RNA;

ADULT; FEMALE; FOLLOW UP; HEALTH SURVEY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTRAVENOUS DRUG ABUSE; LETTER; MAJOR CLINICAL STUDY; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; SEXUAL BEHAVIOR; SEXUAL DYSFUNCTION; VIRUS INFECTION;

FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; ITALY; PATIENT SATISFACTION; QUALITY OF LIFE; REVERSE TRANSCRIPTASE INHIBITORS; SEXUAL BEHAVIOR; SUBSTANCE ABUSE, INTRAVENOUS;

EID: 0344197091     PISSN: 15254135     EISSN: None     Source Type: Journal    
DOI: 10.1097/00126334-200312150-00014     Document Type: Letter

References (11)

1. Schrooten W, Colebunders R, Youle M, et al. Sexual dysfunction associated with protease inhibitor containing highly active antiretroviral treatment. AIDS. 2001;15:1019-1023.
2. Colson AE, Keller MJ, Sax PE, et al. Male sexual dysfunction associated with antiretroviral therapy. J Acquire Immune Defic Syndr. 2002; 30:27-32.
3. Martinez E, Collazos J, Mayo J, et al. Sexual dysfunction with protease inhibitors. Lancet. 1999;353:810-811.
4. Collazos J, Martinez E, Mayo J, et al. Sexual dysfunctions in HIV-infected patients treated with highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31:322-326.
5. Sollima S, Osio M, Muscia F, et al. Protease inhibitors and erectile dysfunction. AIDS. 2001;15:2331-2333.
6. Lallemand F, Salhi Y, Linard F, et al. Sexual dysfunction in 156 ambulatory HIV-infected men receiving highly active antiretroviral therapy combinations with and without protease inhibitors. J Acquir Immune Defic Syndr. 2002;30:187-190.
7. Murri R, Ammassari A, Fantoni M, et al. Disease-related factors associated with health-related quality of life in people with nonadvanced HIV disease assessed using an Italian version of the MOS-HIV Health Survey. J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16:350-356.
8. Revicki DA, Sorensen S, Wu AW. Reliability and validity of physical and mental health summary scores from the Medical Outcomes Study HIV Health Survey. Med Care. 1998;36:126-137.
9. Staszewski S, Morales-Ramirez J, Tashima KT, et al. Efavirenz plus zidovudine and lamivudine, efavirenz plus indinavir, and indinavir plus zidovudine and lamivudine in the treatment of HIV-1 infection in adults. N Engl J Med. 1999;341:1865-1873.
10. Trotta MP, Ammassari A, Cozzi-Lepri A, et al. Adherence to highly active antiretroviral therapy is better in patients receiving non-nucleoside reverse transcriptase inhibitor-containing regimens than in those receiving protease inhibitor-containing regimens. AIDS. 2003;17:1099-1102.
11. Catalan J, Meadows J. Sexual dysfunction in gay and bisexual men with HIV infection: evaluation, treatment and implications. AIDS Care. 2000;12:279-286.